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Most of the cases of dental implant surgery, especially the bone defect extensively, are essential for alveolar ridge augmentation. As
known as cell therapy exerts valuable eﬀects on bone regeneration, numerous reports using various cells from body to regenerate
bone have been published, including clinical reports. Mesenchymal cells that have osteogenic activity and have potential to be
harvested from intra oral site might be a candidate cells to regenerate alveolar bone, even dentists have not been harvested the
cells outside of mouth. This paper presents a summary of somatic cells in edentulous tissues which could subserve alveolar
bone regeneration. The candidate tissues that might have diﬀerentiation potential as mesenchymal cells for bone regeneration
are alveolar bone chip, bone marrow from alveolar bone, periosteal tissue, and gingival tissue. Understanding their phenotype
consecutively will provide a rational approach for alveolar ridge augmentation.
1.Introduction
For increasing the success rate of implant surgery, various
scaﬀolds and methods have been developed to augment
atrophic alveolar ridge. Generally, autologous bone aug-
mentation has been penetrating as a golden standard bone
augmentation; however, most of the patients might not
be feasible for extracting their own bone, just because it
is a healthy part. To avoid aforementioned high-invasive
treatments, cell therapy has recently been researched in this
age of rapid advance.
Combination of mesenchymal cells and ceramic scaﬀold
for bone regeneration has been documented [1]. Cultured
mesenchymal cells introduced into ceramic scaﬀolds exhibits
robust osteogenic potential, with bone forming into pore
regions of scaﬀolds. After this report, numerous reports
using various cells to regenerate bone and sophisticate
reviews for bone regeneration of craniofacial site have been
published [2–7]. Usage of tooth, including periodontal
ligament or pulp, has also been reported that multipoten-
tial stromal cells which are composed above mentioned
were exploited in bone or periodontal regeneration [8, 9].
Although bone augmentation is mostly fundamental to
elderly, they unfortunately follow to edentulous patients in
agingsociety.Thus,thispaperfocusesonadultmesenchymal
cells that could be able to expand from edentulous jaw.
Figure 1 shows the tissues we describe in this paper by
sectional scheme of edentulous alveolar ridge.
2. AlveolarBone Chips
Osteoblasts-like cells migrated from alveolar bone chips have
generally high osteogenic activity. Essentially, mammalian
bones are in the form of two diﬀerent ways: long bones
via endochondral ossiﬁcation and ﬂat bones via intramem-
branous ossiﬁcation. Orofacial bone is mainly formed via
intramembranous ossiﬁcation, and a part of mandibular
is formed via endochondral ossiﬁcation. These bony types
show considerable diﬀerences in protein composition [10].
Harvesting bony chips from various sites implicate that
origins of the osteoblastic cells (from maxilla or mandibu-
lar, from cortical or trabecular bone) are distinct from
each reports; furthermore osteogenic activity, expression2 International Journal of Dentistry
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Figure 1: Sectional scheme of edentulous alveolar ridge. Figure
shows the origin of candidate tissues and the cells we could harvest
from alveolar bone chip, bone marrow, periosteum, and gingiva.
of surface antigens, or ability for ectopic bone formations
might be diﬀerent among each report, beside cell isolation
protocols are diﬀerent among each report. Majority of
culture protocol of osteogenic cells from alveolar bone are
wash bone specimens in PBS, scrape to remove attached soft
tissue and periosteum, brake into small pieces, and wash
withcollagenase(1to2mg/mL)dissolvedinculturemedium
[11, 12]. In some reports, osteogenic cells were collected
without collagenase [13–15]. However, despite harvesting
bony chips from healthy site is essential when we use these
in clinic, it is not feasible for all patients just because of
the invasive operation. In addition, it is still not clear how
amount of bony chips is enough to regenerate each part of
alveolar ridge and which part of bone cells are suitable to
k e e pa u g m e n t e db o n ev o l u m eo nl o n gp r o g n o s i s .
3. Bone Marrow from Alveolar Bone
The reason why iliac crest bone marrow is the most docu-
mented bone marrow transplantation is because they have
been corrected for bone marrow transplantation in clinic
as usual. Bone marrow stromal cells (BMSCs) have been
reported their ability of multipotent diﬀerentiation to bone,
cartilage, tendon, muscle, adipose tissue, and neuronal tissue
[16–18]. Bone regenerative clinical studies using BMSCs,
collectedfromiliaccresttoreconstructjawdefects,havebeen
reported [19, 20]. Kawaguchi et al. reported that iliac crest
BMSCs enhance periodontal tissue regeneration as well [21,
22]. Alveolar BMSCs, however, is essentially diﬀerent from
axial BMSCs from their diﬀerential potential or their gene
expression pattern [23, 24]. Embryologically, alveolar tissues
including alveolar bone marrow are originated from neural
crest cells, but other bone marrows are from mesoderm
[25, 26]. Cherubism [27], Treacher Collins syndrome [28],
craniofacial ﬁbrous dysplasia [29], and hyperparathyroid
jaw tumor syndrome [30]a ﬀect only jaw bones, indicating
that orofacial bone development diﬀers from that of axial
and appendicular bone formation. Whitaker’s group have
reported that membranous bone underwent less resorption
than endochondral bone in monkey model [31], and they
found the rapid vascularization on membranous onlay
bone grafts in rabbit model [32]. In human alveolar cleft
defects, chin bone was better incorporated, signiﬁcantly less
resorbedthaniliaccrestbone[33,34].Inhistomorphometry,
autologous grafts obtained from calvarial sources for sinus
lift procedure present a signiﬁcantly higher degree of bone
volume in contrast to bone harvested from the iliac crest
[35]. In in vitro and in vivo study, Akintoye et al. have
investigated skeletal site-speciﬁc phenotypic and functional
diﬀerences between orofacial (maxilla and mandible) and
axial (iliac crest) human BMSCs. Compared with iliac crest
cells,orofacialBMSCsproliferatedmorerapidlywithdelayed
senescence, expressed higher levels of alkaline phosphatase,
and demonstrated more calcium accumulation in vitro.
Orofacial BMSCs formed more bone in vivo, while iliac
crest BMSCs formed more compacted bone that included
hematopoietic tissue and were more responsive in vitro and
in vivo to osteogenic and adipogenic inductions [36]. Com-
paring with the osteogenic properties of BMSCs attached on
titanium for evaluating the avidity bone to implant exhibited
that there was no diﬀerence in the aﬃnity of maxilla and iliac
crestBMSCstotitanium.Titanium-attachedmaxillaBMSCs,
however, were apparently more osteogenically responsive
than iliac crestcellsbasedon calciumaccumulationandgene
expression of alkaline phosphatase and osteopontin [37].
Akintoye et al. have also studied the skeletal site-speciﬁc
osteogenic response of BMSC to BMP-2 stimulation [38].
They reported orofacial BMSC displayed high expression
of osteogenic markers in response to BMP-2 in contrast
to the low response of adult iliac crest BMSC. They also
reported that mandible BMSCs were more susceptible to
bisphosphonates than iliac crest BMSC [39]; orofacial BMSC
survived higher radiation doses and recovered quicker than
iliac crest BMSC [40]. Osteoclastogenic potential of jaw
and long-bone-derived osteoclasts have diﬀerent dynamics,
and this might primarily due to diﬀerences in the cellular
composition of the bone site-speciﬁc marrow [41]. Aghaloo
et al. established a protocol for rat mandible and long-bone
marrow stromal cell isolation and culture. Upon implanta-
tion into nude mice, mandible BMSCs formed 70% larger
bone nodules containing three-fold more mineralized bone
compared with long-bone BMSCs [42]. Alveolar BMSCs are
obtained from older individuals, and the donor age has little
eﬀect on their gene expression pattern [43]. According to
aforementioned studies, usageof alveolar BMSCs might have
high advantages for alveolar bone regeneration compared
with iliac BMSCs; however, establishing the protocol of
harvesting BMSCs in low invasive way is still unclear.International Journal of Dentistry 3
4. PeriostealTissuefrom Oral Site
Usage of periosteal cells from periosteum was originally
reported by Breitbart et al. on rabbit experiments [44].
Outgrowthed periosteal cells were cultured with dexam-
ethasone contained medium, and cell/polyglycolic acid non-
woven ﬁver scaﬀolds complex showed signiﬁcant bone
formation on calvarial defect compared with scaﬀold only.
Adult human periosteal cells from tibia include multipotent
clonogenic cells [45], while, in the case of oral tissue,
periosteal cells isolated from the mandibular angle of
human with β-tricalcium phosphate granules have shown
that combined treatment with bFGF and BMP-2 can make
periosteal cells a highly useful source of bone regeneration
[46]. In nude mouse subcutaneously model, acid-treated
HA block cultured with human periosteal cells complex had
signiﬁcant osteogenic potential at the site of implantation
in vivo [47], while in canine model for peri-implant bone
regeneration, periosteum-derived cells in conjunction with
e-PTFE membranes did not provide additional beneﬁt [48].
Comparing with proliferated periosteal cells, Cicconetti et al.
harv est edmarr o wc ellsfr ommaxillarytuber ositybone.They
concluded that both periosteal cells and marrow stromal
cells showed comparable phenotypic proﬁles and both cell
populations formed bone upon ectopic in vivo transplan-
tation [49]. Harvesting periosteal cells is relatively invasive
treatment; for instance, it is still unclear the collection
quantity for required bone regeneration and also periosteal
tissue is hard to collect by general practitioners.
5.GingivalTissue
During dental surgery, gingival tissue could be obtained
frequently as a discarded biological sample. Wound healing
within the gingiva is characterized by markedly reduced
inﬂammation, scarless healing, rapid reepithelialization,
contrary to the common scar formation present in skin
[50,51].Recently,severalreports have indicated the presence
of progenitor cells in gingival connective tissue [52, 53].
Tang et al. reported gingival tissue contains tissue-speciﬁc
mesenchymal stem cell population and is an ideal resource
for immunoregulatory therapy, using human normal and
hyperplastic gingival tissues [54]. The ratio of these pro-
genitors in gingival ﬁbroblasts, however, might be very
low rather than bone marrow, periosteal tissue, or bone
chips. Nevertheless, enrichment of progenitor cells that show
characteristics with of diﬀerentiation as osteoblastic cells
entail for usage in bone tissue engineering.
6. Conclusion
Bone marrow-derived cells, called mononuclear cells or
marrow mesenchymal cells, are essentially diﬀerent from
osteoblastic cells derived from bone chip. In a case of
small animal model, it is hard to separate mandibular
bone marrow cells to bone lining osteoblastic cells [55]. In
bulk, however, this bone/BMSCs possess unique stem cell
properties that the size of alveolar bone has restrained the
preciseanalysisofBMSCsphenotype.Furthermore,diversity
of culture methods made us to confuse. As we use outgrowth
cells from tissues on the other side, the population cultured
cells is inﬂuenced by their migration ability. Treating tissue
with enzyme to disperse cells from tissue, however, cell
population is not dependent on migration ability. Thus,
developing stable and universal methods to harvest and
cultureosteogeniccellsforboneregenerationisprerequisite.
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